Feed PRVCF
PR

PreveCeutical Medical Inc.

PRVCF · OTC

$0.01 -0.69% (-$0.00)
1M -3.33%
Market Cap $12.1M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9
Valuation
-
N/A
P/FCF N/A
P/E N/A
EV/FFO N/A
Growth
-
N/A
FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A
Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
57 /100
Average
Asset turnover 0.00x
ROIC 339.03%
ROA 109.38%
Debt
0 /100
High
Int. coverage -10.44x
Current ratio 0.15x
Debt/Assets N/A
Stability
39 /100
Moderate
Profitable years 0
Beta 0.07x
EPS volatility 19.88%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o PRVCF
Online

Sector

Healthcare

Industry

Biotechnology

CEO

Stephen Van Deventer

Employees

7

Headquarters

Vancouver

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.